In vitro Phase I and Phase II metabolism of α-pyrrolidinovalerophenone (α-PVP), methylenedioxypyrovalerone (MDPV) and methedrone by human liver microsomes and human liver cytosol.
about
Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013-2016: A Review.Identification of phase I and II metabolites of the new designer drug α-pyrrolidinohexiophenone (α-PHP) in human urine by liquid chromatography quadrupole time-of-flight mass spectrometry (LC-QTOF-MS).In vitro, in vivo and in silico metabolic profiling of α-pyrrolidinopentiothiophenone, a novel thiophene stimulant.Microbial biotransformation of five pyrrolidinophenone-type psychoactive substances in wastewater and a wastewater isolated Pseudomonas putida strain.Metabolism of novel opioid agonists U-47700 and U-49900 using human liver microsomes with confirmation in authentic urine specimens from drug users.Neurobiology of 3,4-methylenedioxypyrovalerone (MDPV) and α-pyrrolidinovalerophenone (α-PVP).Synthetic cathinone pharmacokinetics, analytical methods, and toxicological findings from human performance and postmortem cases.New psychoactive substances: an overview on recent publications on their toxicodynamics and toxicokinetics.Editor's Highlight: Characterization of Hepatotoxicity Mechanisms Triggered by Designer Cathinone Drugs (β-Keto Amphetamines).Identification of in vitro and in vivo human metabolites of the new psychoactive substance nitracaine by liquid chromatography coupled to quadrupole time-of-flight mass spectrometry.First metabolic profile of PV8, a novel synthetic cathinone, in human hepatocytes and urine by high-resolution mass spectrometry.Alpha-PVP as an active component of herbal highs in Poland between 2013 and 2015.Study of the in vitro and in vivo metabolism of the tryptamine 5-MeO-MiPT using human liver microsomes and real case samples.Metabolism of α-PHP and α-PHPP in humans and the effects of alkyl chain lengths on the metabolism of α-pyrrolidinophenone-type designer drugs.α-PVP (“flakka”): a new synthetic cathinone invades the drug arena
P2860
Q30148688-741EC1A0-406D-4B7A-A2A9-5B1D3FF3FF7DQ34499556-268D8799-DFED-49A6-91B0-3FD1A7133A6EQ34504512-55B84A09-9361-472F-A777-B717129C1B14Q36250569-8F43F87F-ECF4-4398-B4F5-79DE8DF58E9CQ38728210-67812059-CB80-40CF-B6A9-EFD26725FA93Q38824564-95C32AF6-86BA-438B-BDF4-58ED5743ABCCQ38850097-EA140F14-102B-4794-8B42-906B132BDF0CQ38963846-F184A3E6-8D99-409B-A654-44D46A5515E0Q39714625-8FE09F43-8A9D-468B-81D2-A13081C911A0Q39761673-E91A6D33-274F-46AA-BC65-242CDBBB1A42Q39761680-6CC54550-B181-4BAD-B2EC-7950A7C88A1CQ47595737-9670C746-FB40-41C9-86FC-41B36236E275Q48176029-B861EE1B-6FA4-419A-9556-D0FA2DFAFCBEQ55367903-EE933421-C2A3-4F70-A740-F1F556755767Q59218491-76566A5F-CE9C-4C58-8319-52082F3C1713
P2860
In vitro Phase I and Phase II metabolism of α-pyrrolidinovalerophenone (α-PVP), methylenedioxypyrovalerone (MDPV) and methedrone by human liver microsomes and human liver cytosol.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
In vitro Phase I and Phase II ...... somes and human liver cytosol.
@en
In vitro Phase I and Phase II ...... somes and human liver cytosol.
@nl
type
label
In vitro Phase I and Phase II ...... somes and human liver cytosol.
@en
In vitro Phase I and Phase II ...... somes and human liver cytosol.
@nl
prefLabel
In vitro Phase I and Phase II ...... somes and human liver cytosol.
@en
In vitro Phase I and Phase II ...... somes and human liver cytosol.
@nl
P2860
P50
P1476
In vitro Phase I and Phase II ...... osomes and human liver cytosol
@en
P2093
Ester Heath
P2860
P2888
P304
P356
10.1007/S00216-015-8763-6
P407
P577
2015-05-27T00:00:00Z
P6179
1017921824